AOD-9604
A fragment of the end of the growth hormone molecule, developed in Australia as a potential anti-obesity drug. Clinical trials in the 2000s did not lead to approval.
Level of evidence
Clinical trials — controlled human studiesWhat it is
AOD-9604 corresponds to amino acids 177–191 of human growth hormone with an added tyrosine at the N-terminus. It is closely related to the “HGH fragment 176-191”.
State of the research
It was studied in clinical trials as an anti-obesity drug in the 2000s. The trials did not show a significant effect on body weight and development as a medicine was stopped.
Sources
Last reviewed: October 2026
Summaries of published scientific literature, for information and laboratory research only. They do not describe uses of our products, are not medical advice and do not imply that any compound is safe or effective in humans. Our products are not for human or animal consumption.